文献速递主动脉疾病外周动脉疾病

严重多血管旁内脏与主髂动脉闭塞性疾病患者的主动脉内膜剥脱术

Aortic endarterectomy in patients with severe multivessel paravisceral and aortoiliac occlusive disease.
PubMed 文献 · J Vasc Surg · 2023-12-22

单中心回顾性分析2017至2023年20例接受主动脉内膜剥脱术的患者,5例为旁内脏段、15例为主髂段。围术期无死亡,旁内脏组1年一期通畅率40%、一期辅助通畅率80%、二期通畅率100%;主髂组分别为91%、91%、100%。术后踝肱指数中位改善右侧+0.59、左侧+0.56(P<.01)。

要点

  • 旁内脏组3例需再干预,其中2例因肠系膜上动脉远端吻合口狭窄行支架置入。
  • 主髂组1年一期通畅率91%,旁内脏组为40%,但二期通畅率均达100%。
  • 术后踝肱指数中位右侧1.06、左侧1.00,较术前中位改善右+0.59、左+0.56(P<.01)。

核心结论

  • 在20例接受旁内脏与肾下主髂动脉内膜剥脱术的患者中,围术期无死亡,并发症相对低且可控,临床结局良好。
  • 旁内脏组肠系膜上动脉相关早期再干预并不少见,尤其需关注内膜剥脱远端部位。
  • 对于病变局限于主动脉与髂总动脉的严重多血管旁内脏或主髂动脉闭塞性疾病,主动脉内膜剥脱术仍是可选治疗。

研究设计与样本

  • 单中心回顾性研究,纳入2017至2023年接受主动脉内膜剥脱术的20例患者。
  • 5例(25%)行旁内脏段内膜剥脱术,15例(75%)行主髂段内膜剥脱术。

主要发现

  • 围术期无死亡;1例旁内脏组患者术后3个月死于肺炎并发症。
  • 旁内脏组1年一期通畅率40%、一期辅助通畅率80%、二期通畅率100%;主髂组分别为91%、91%、100%。
  • 旁内脏组3例再干预:术后第0天肠系膜上动脉血栓形成行内膜剥脱扩大及补片血管成形术;术后1个月远端狭窄行肠系膜上动脉支架置入;术后10个月随访时远端狭窄行支架置入。
  • 主髂组1例术后10天因内膜剥脱远端内膜片致髂动脉血栓形成,她与另1例年轻男性(未定义的高凝状态)分别于术后18和32个月行新主髂动脉重建(后者在停用抗凝期间发生)。
  • 其余13例无并发症;所有患者临床症状迅速缓解,术后踝肱指数中位右侧1.06、左侧1.00,较术前中位改善右+0.59、左+0.56(P<.01和P<.01)。

临床怎么用

  • 作者认为,对于病变局限于主动脉与髂总动脉的严重多血管旁内脏或主髂动脉闭塞性疾病,主动脉内膜剥脱术仍是可选治疗。
  • 作者指出,旁内脏组肠系膜上动脉相关早期再干预并不少见,尤其需关注内膜剥脱远端部位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aortic endarterectomy (AE), once a treatment of choice for aortoiliac occlusive disease, is now rarely performed in favor of endovascular procedures or open aortobifemoral bypass. However, in select patients with paravisceral or aortoiliac occlusive disease, AE remains a viable alternative for revascularization, either as a primary procedure or after prior interventions have failed. Here, we evaluated outcomes for an extended series of patients undergoing paravisceral or aortoiliac endarterectomy, demonstrating that these procedures can be an excellent alternative with acceptable morbidity and mortality in properly selected patients. METHODS: A single institution retrospective review of 20 patients who underwent AE from 2017 to 2023 was performed. RESULTS: Five patients (25%) underwent paravisceral endarterectomy and 15 (75%) underwent aortoiliac endarterectomy. There were no perioperative mortalities. One paravisceral patient died 3 months postoperatively from complications of pneumonia. Three patients in the paravisceral group required reinterventions; one acutely due to thrombosis of the superior mesenteric artery (SMA) requiring extension of the endarterectomy and patch angioplasty on postoperative day 0, one due to stenosis at the distal edge of the endarterectomy 1 month postoperatively, successfully treated with SMA stenting, and one at 10-month follow-up due to SMA stenosis at the distal aspect of the endarterectomy, also successfully treated with SMA stenting. With these reinterventions, the 1-year primary patency in the paravisceral group was 40%, primary-assisted patency was 80%, and secondary patency was 100%. In the aortoiliac group, 1-year primary, primary-assisted, and secondary patency were 91%, 91%, and 100%, respectively. One patient developed iliac thrombosis 10 days postoperatively owing to an intimal flap distal to the endarterectomy site. She and one other patient, a young man with an undefined hypercoagulable disorder, ultimately required neoaortoiliac reconstructions at 18 and 32 months postoperatively, respectively (the latter in the setting of stopping anticoagulation). The remaining 13 patients experienced no complications. All patients had rapid resolution of clinical symptoms, and median postoperative ankle-brachial indexes of 1.06 on the right and 1.00 on the left, representing a median improvement from preoperative ankle-brachial indexes of +0.59 on the right and +0.56 on the left (P < .01 and P < .01). CONCLUSIONS: In this series of 20 patients undergoing paravisceral and infrarenal aortoiliac endarterectomy, AE was associated with no perioperative mortality, relatively low and manageable morbidity, and excellent clinical outcomes in patients with both paravisceral and aortoiliac occlusive disease. SMA-related early reintervention was not uncommon in the paravisceral group, and attention should be given particularly to the distal endarterectomy site. AE remains a viable treatment for severe multivessel paravisceral or aortoiliac occlusive disease isolated to the aorta and common iliac arteries in select patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Motyl CM, Pearce BJ, Spangler EL, et al. Aortic endarterectomy in patients with severe multivessel paravisceral and aortoiliac occlusive disease. J Vasc Surg. 2023. PMID: 38141738. doi:10.1016/j.jvs.2023.11.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。